LGL Group (NYSEAMERICAN:LGL) Stock Passes Above Two Hundred Day Moving Average – Here’s What Happened

LGL Group, Inc. (The) (NYSEAMERICAN:LGL) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.87 and traded as high as $6.93. LGL Group shares last traded at $6.90, with a volume of 4,138 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research raised shares of LGL Group to a “hold” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

LGL Group Stock Performance

The firm has a market cap of $45.13 million, a PE ratio of 690.69 and a beta of 0.32. The stock has a fifty day moving average price of $6.97 and a 200-day moving average price of $6.87.

Institutional Trading of LGL Group

A number of institutional investors have recently added to or reduced their stakes in LGL. Citadel Advisors LLC purchased a new stake in LGL Group during the 3rd quarter worth $90,000. Osaic Holdings Inc. raised its position in LGL Group by 15.5% in the second quarter. Osaic Holdings Inc. now owns 20,250 shares of the industrial products company’s stock valued at $154,000 after purchasing an additional 2,710 shares during the period. Renaissance Technologies LLC raised its position in LGL Group by 3.6% in the first quarter. Renaissance Technologies LLC now owns 166,594 shares of the industrial products company’s stock valued at $1,158,000 after purchasing an additional 5,773 shares during the period. Finally, Gamco Investors INC. ET AL lifted its stake in shares of LGL Group by 2.8% during the first quarter. Gamco Investors INC. ET AL now owns 670,781 shares of the industrial products company’s stock worth $4,662,000 after purchasing an additional 18,305 shares in the last quarter. 30.28% of the stock is owned by hedge funds and other institutional investors.

About LGL Group

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.